Two Mount Sinai Experts Receive Honors From the National Multiple Sclerosis Society
Fred Lublin, MD, and Aaron Miller, MD, honored with the Hope Award for the impact of their pivotal research and clinical expertise
Two of Mount Sinai’s top multiple sclerosis (MS) experts were honored with the prestigious Hope Award at the National Multiple Sclerosis Society’s annual Dinner of Champions, which took place in person at the Edison Ballroom Rooftop on Monday, September 13.
Fred Lublin, MD, Saunders Family Professor of Neurology and Director of The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, and Aaron Miller, MD, Professor of Neurology and Medical Director of The Corinne Goldsmith Dickinson Center, were selected for this honor in recognition of their pivotal research and clinical acumen that has inspired hope in the lives of countless MS patients, their families, and the community of people around the country who are affected by this disabling disease.
“Drs. Lublin and Miller are both outstanding clinician-researchers and educators, who have each made indelible impacts on our understanding of and treatment for multiple sclerosis,” said Barbara Vickrey, MD, MPH, Professor and Chair of Neurology at the Icahn School of Medicine at Mount Sinai. “Their tireless commitment to MS patients, their families, and the education of clinicians who care for this community is exemplary. We are proud and grateful to the National Multiple Sclerosis Society for recognizing their excellence with this honor.”
Dr. Lublin is an internationally renowned authority on the scientific and clinical aspects of MS and is one of the foremost authorities regarding experimental therapies. As a neuroimmunologist, he has a special interest in immune functions and abnormalities that affect the nervous system. He has been involved in both clinical and basic science research. A member of many professional societies and advisory boards, Dr. Lublin has previously served as Chairman of the National Multiple Sclerosis Society advisory committee on clinical trials of new MS drugs, Chair of the Clinical Advisory Committee of the New York City chapter of the National Multiple Sclerosis Society, and as a national board member of the Society.
Dr. Miller is a leading neurologist and expert who has held leadership positions for multiple MS programs and professional organizations throughout his illustrious career. Specially trained in neurovirology and immunology, Dr. Miller is the immediate past Chairman of the National Medical Advisory Committee of the National Multiple Sclerosis Society and past president of the Consortium of MS Centers. He was the first president of the Section on Multiple Sclerosis of the American Academy of Neurology and has participated in numerous clinical trials of new treatments for MS. Prior to assuming the position of Medical Director of The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai in 2004, he spent 23 years leading the Division of Neurology at Maimonides Medical Center. He has authored three books focused on MS, and has served as the editor of Continuum, a continuing education publication of the American Academy of Neurology.
“We are thrilled to honor Drs. Aaron Miller and Fred Lublin as the 2021 Hope Honorees. As global MS research leaders, they have made landmark contributions to how we diagnose and treat MS and to the development of the disease-modifying treatments that have improved the lives of people with MS,” said Tim Coetzee, PhD, Chief Advocacy, Services and Research Officer for the National Multiple Sclerosis Society. “Through their work at The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, they have set the standard for delivery of comprehensive, high-quality MS care. Beyond that, they have guided the development of MS specialists who are now leaders in the MS movement and are a source of inspiration and hope for everyone in our movement.”
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.